JPMorgan Chase (AMJB) prospectus addendum permits note reopenings and market‑making

Rhea-AI Filing Summary

JPMorgan Chase & Co. and JPMorgan Chase Financial Company LLC filed a prospectus addendum dated April 17, 2026 that supersedes prior prospectuses and supplements dated on or before that date. The addendum permits these documents to be used for reopenings of notes and for market‑making transactions in notes originally issued under earlier prospectuses.

Key Figures

Prospectus addendum date: April 17, 2026 Registration statement nos.: 333-293684, 333-293684-01 Referenced registration examples: 333-199966; 333-270004

3 metrics

Prospectus addendum date April 17, 2026 Effective date of the addendum and Prospectus Supplement

Registration statement nos. 333-293684, 333-293684-01 Filed with the Securities and Exchange Commission

Referenced registration examples 333-199966; 333-270004 Examples of prior registration statements superseded by the addendum

Key Terms

prospectus addendum, reopening, market‑making transactions, Prospectus Supplement

4 terms

prospectus addendum regulatory

"Prospectus addendum To the prospectus dated April 17, 2026"

reopening financial

"use this prospectus addendum ... in connection with reopening of notes"

market‑making transactions market

"use this prospectus addendum ... in connection with ... market‑making transactions of notes"

Prospectus Supplement regulatory

"the prospectus supplement dated April 17, 2026 (the “Prospectus Supplement”)"

A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/17/2026 - 04:49 PM Learn about SEC filing dates

FAQ

What does the JPMorgan Chase prospectus addendum dated April 17, 2026 do?

It supersedes earlier prospectuses and supplements dated on or before April 17, 2026. The addendum allows the company and affiliates to use the updated prospectus and supplement for reopenings of notes and market‑making transactions in notes issued under prior prospectuses.

Does the addendum change investor protections or FDIC coverage for the notes?

No — the notes are not bank deposits and are not FDIC insured. The addendum reiterates that the notes are not obligations of, or guaranteed by, a bank and that no regulator has approved or disapproved the notes.

Which registration statements does the addendum reference?

It references multiple registration statements, including Nos. 333-199966 and 333-270004. The addendum states it supersedes prospectuses and supplements filed under those and other listed registration statement numbers dated on or before April 17, 2026.

Can affiliates use the prospectus addendum for market‑making and reopenings?

Yes — the filing states JPMorgan Chase & Co. and JPMorgan Chase Financial Company LLC will use it, and other affiliates may use it. The permitted uses specifically include reopenings of notes and market‑making transactions for notes originally issued under earlier prospectuses.

Prospectus addendum To the prospectus dated April 17, 2026 and the prospectus supplement dated April 17, 2026	Registration Statement Nos. 333-293684 and 333-293684-01 Dated April 17, 2026 Rule 424(b)(3)
JPMorgan Chase & Co.	JPMorgan Chase Financial Company LLC

JPMorgan Chase & Co. and JPMorgan Chase Financial Company LLC have filed with the Securities and Exchange Commission a prospectus dated April 17, 2026 (the “Prospectus”) and a prospectus supplement dated April 17, 2026 (the “Prospectus Supplement”), which, except as set forth below, supersede each prospectus supplement and prospectus previously filed with the Securities and Exchange Commission by JPMorgan Chase & Co. under the registration statements with the following file numbers: 333-199966, 333-177923, 333-155535 and 333-130051 and by JPMorgan Chase & Co. and JPMorgan Chase Financial Company LLC under the registration statement with the following file numbers: 333-270004, 333-270004-01, 333-236659, 333-236659-01, 333-222672, 333-222672-01, 333-209682 and 333-209682-01.

With respect to each pricing supplement, reopening supplement, reopening pricing supplement, product supplement or underlying supplement dated on or prior to April 17, 2026 (each, a “Relevant Supplement”):

· all references to a prospectus of JPMorgan Chase & Co. and/or JPMorgan Chase Financial Company LLC dated prior to April 17, 2026 (a “Previously Filed Prospectus”) (or to any section of any such Previously Filed Prospectus) should refer instead to the Prospectus (or to the corresponding section of the Prospectus); and

· all references to a prospectus supplement of JPMorgan Chase & Co. and/or JPMorgan Chase Financial Company LLC dated prior to April 17, 2026 (a “Previously Filed Prospectus Supplement”) (or to any section of any such Previously Filed Prospectus Supplement) should refer instead to the Prospectus Supplement (or to the corresponding section of the Prospectus Supplement);

provided that:

· unless otherwise specified in a future supplement or addendum, in connection with the specific notes referred to in any Relevant Supplement, any discussion in connection with tax treatment or tax consequences of the relevant notes in the Prospectus Supplement shall be disregarded;

· all references to the “Forms of Securities — Book-Entry System” section of a prospectus dated prior to November 14, 2011 and all references to the “The Depositary” section of a prospectus supplement dated prior to November 14, 2011 shall be deemed to refer to the section entitled “Forms of Securities — Book-Entry System” in the Prospectus; and

· in connection with the specific notes of JPMorgan Chase & Co. referred to in any Relevant Supplement (the “Relevant Notes”), all references to the “indenture” or “Indenture” of JPMorgan Chase & Co. (the “Indenture”) and to any of its terms or any terms of the notes governed by the Indenture are to the Indenture dated May 25, 2001, between JPMorgan Chase & Co. and Deutsche Bank Trust Company Americas (formerly Bankers Trust Company), as trustee, as amended by any supplemental indenture that, by its terms and as specified in the Previously Filed Prospectus and Previously Filed Prospectus Supplement, applies to the Relevant Notes. Accordingly, unless otherwise specified in a future supplement or addendum, the description of the Indenture and of the provisions of the notes governed by the Indenture contained in the Previously Filed Prospectus and Previously Filed Prospectus Supplement is not superseded and remains in effect.

JPMorgan Chase & Co. and JPMorgan Chase Financial Company LLC will, and other affiliates of JPMorgan Chase & Co. and JPMorgan Chase Financial Company LLC may, use this prospectus addendum and the Prospectus and Prospectus Supplement in connection with reopening of notes or market-making transactions of notes originally issued under any prospectus dated prior to April 17, 2026 and any prospectus supplement dated prior to April 17, 2026.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of the notes or passed upon the accuracy or the adequacy of this prospectus addendum or any Relevant Supplement, the Prospectus Supplement or the Prospectus. Any representation to the contrary is a criminal offense.

The notes are not bank deposits, are not insured by the Federal Deposit Insurance Corporation or any other governmental agency and are not obligations of, or guaranteed by, a bank.

 

April 17, 2026